Profound Medical Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Profound Medical Corp. on April 1, 2026. The Company, incorporated in Ontario, Canada, operates on the Nasdaq Stock Market under the symbol PROF. The report focuses on a regulatory disclosure regarding upcoming scientific presentations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial statements or performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the announcement that the Company's interventional MRI TULSA Procedure will be featured in several presentations at the 2026 Society of Interventional Radiology Annual Scientific Meeting in Toronto, ON, from April 11-15, 2026.
Guidance, Outlook, and Risks
The filing includes no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies are detailed in this report, other than the standard disclaimer that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for details on the TULSA Procedure presentations.
- Confirm the dates and location of the 2026 Society of Interventional Radiology Annual Scientific Meeting (April 11-15, 2026, Toronto, ON).
- Review subsequent filings for any financial impact or strategic updates resulting from the scientific meeting.